Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease.
In order to investigate the possible role of oxidative RNA damage in the pathogenesis of Parkinson's disease (PD), the concentrations of the oxidative stress marker 8-hydroxyguanosine (8-OHG) were measured in the cerebrospinal fluid (CSF) and the serum of patients with PD and control subjects. The concentration of 8-OHG in CSF in PD patients was approximately three-fold that in controls (P < 0.001). The concentration of 8-OHG in CSF decreased significantly with the duration of disease (r(s) = -0.46, P < 0.05). However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls. In addition, the concentration of 8-OHG in CSF showed no correlation with that in serum in both the controls and PD patients suggesting that the 8-OHG concentrations in the CSF do not reflect those in serum and may be probably reflect those in brain tissue. These in vivo findings suggest a possible role of 8-OHG and increased oxidative RNA damage in the early stage of the development of PD.
Abe
Takashi
T
Department of Neurology, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate, Japan.
Isobe
Chiaki
C
Murata
Takahiko
T
Sato
Chigumi
C
Tohgi
Hideo
H
D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D005260:Female; D006151:Guanosine / Q000031:analogs & derivatives* / Q000097:blood* / Q000134:cerebrospinal fluid*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018384:Oxidative Stress; D010300:Parkinson Disease / Q000097:blood* / Q000134:cerebrospinal fluid*; D012313:RNA / Q000378:metabolism; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013223:Statistics as Topic
D015415:Biomarkers; D006151:Guanosine; C046215:8-hydroxyguanosine; D012313:RNA